Comparison of inhibitory effects of glucosamine and mannosamine on bovine articular cartilage degradation in vitro

American Journal of Veterinary Research

Volumn 65, Issue 10, 2004, Pages 1440-1445

  Mello, David M ^a   Nielsen, Brian D ^a   Peters, Tonia L ^a   Caron, John P ^a   Orth, Michael W ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATIN; GLUCOSAMINE; LIPOPOLYSACCHARIDE; MANNOSAMINE; MATRIX METALLOPROTEINASE; NITRIC OXIDE; NITRITE; PROTEOGLYCAN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; CATTLE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; DRUG CYTOTOXICITY; DRUG MECHANISM; ENZYME ACTIVITY; EXPERIMENTATION; EXPLANT; EXPOSURE; IN VITRO STUDY; NONHUMAN; PROTEIN SECRETION; TISSUE CULTURE; ZYMOGRAPHY;

ANIMALS; CARTILAGE; CATTLE; CATTLE DISEASES; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSAMINE; HEXOSAMINES; LIPOPOLYSACCHARIDES; MATRIX METALLOPROTEINASES; NITRIC OXIDE; OSTEOARTHRITIS; PROTEOGLYCANS;

ANIMALIA; BOS TAURUS; BOVINAE;

EID: 5644270235     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2004.65.1440     Document Type: Article

References (40)

1. Hochberg MC, Altman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum 1995; 38:1541-1546.
2. Hochberg MC, Altman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part 1. Osteoarthritis of the hip. American College of Rheumatology. Arthritis Rheum 1995; 38:1535-1540.
3. Shoemaker RS, Bertone AL, Martin GS, et al. Effects of intra-articular administration of methylprednisolone acetate on normal articular cartilage and on healing of experimentally induced osteochondral defects in horses. Am J Vet Res 1992;53:1446-1453.
4. Trotter GW, McIlwraith CW, Yovich JV, et al. Effects of intraarticular administration of methylprednisolone acetate on normal equine articular cartilage. Am J Vet Res 1991;52:83-87.
5. Baxter J. Traumatic synovitis in the performance horse and its contribution to osteoarthritis. Equine Athlete 1992;5:18-23.
6. Hungerford D, Navarro R, Hammad TA. Use of nutraceuticals in the management of osteoarthritis. J Am Nutraceutical Assoc 2000; 3:23-27.
7. Deal CL, Moskowitz RW. Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate. Rheum Dis Clin North Am 1999;25:379-395.
8. Setnikar I, Giacchetti C, Zanolo G. Pharmacokinetics of glucosamine in the dog and in man. Arzneimittelforschung 1986;36:729-735.
9. Barclay TS, Tsourounis C, McCart GM. Glucosamine. Ann Pharmacother 1998;32:574-579.
10. da Camara CC, Dowless GV. Glucosamine sulfate for osteoarthritis. Ann Pharmacother 1998;32:580-587.
11. Crolle G, D'Este E. Glucosamine sulphate for the management of arthrosis: a controlled clinical investigation. Curr Med Res Opin 1980;7:104-109.
12. Pujalte JM, Llavore EP, Ylescupidez FR. Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthrosis. Curr Med Res Opin 1980;7:110-114.
13. Houpt JB, McMillan R, Wein C, et al. Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee. J Rheumatol 1999;26:2423-2430.
14. Reginster JY, Deroisy R, Rovati LC, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 2001;357:251-256.
15. Oegema TR Jr, Deloria LB, Sandy JD, et al. Effect of oral glucosamine on cartilage and meniscus in normal and chymopapain-injected knees of young rabbits. Arthritis Rheum 2002;46:2495-2503.
16. Fenton JI, Chlebek-Brown KA, Peters TL, et al. The effects of glucosamine derivatives on equine cartilage degradation in explant culture. Osteoarthritis Cartilage 2000;8:444-451.
17. Fenton JI, Chlebek-Brown KA, Peters TL, et al. Glucosamine HCl reduces equine articular cartilage degradation in explant culture. Osteoarthritis Cartilage 2000;8:258-265.
18. Sandy JD, Thompson V, Verscharen C, et al. Chondrocyte-mediated catabolism of aggrecan: evidence for a glycosylphosphatidylinositol-linked protein in the aggrecanase response to interleukin-1 or retinoic acid. Arch Biochem Biophys 1999;367:258-264.
19. Chandrasekhar A, Esterman MA, Hoffman HA. Microdetermination of proteoglycans and glycosaminoglycans in the presence of guanidine hydrochloride. Anal Biochem 1987;161:103-108.
20. Ewers BJ, Dvoracek-Driksna D, Orth MW, et al. The extent of matrix damage and chondrocyte death in mechanically traumatized articular cartilage explants depends on rate of loading. J Orthop Res 2001;19:779-784.
21. Fernandes JC, Martel-Pelletier J, Otterness IG, et al. Effects of tenidap on canine experimental osteoarthritis. I. Morphologic and metalloprotease analysis. Arthritis Rheum 1995;38:1290-1303.
22. de Mattei M, Pellati A, Pasello M, et al. High doses of glucosamine-HCl have detrimental effects on bovine articular cartilage explants cultured in vitro. Osteoarthritis Cartilage 2002;10:816-825.
23. Ilic MZ, Martinac B, Handley CJ. Effects of long-term exposure to glucosamine and mannosamine on aggrecan degradation in articular cartilage. Osteoarthritis Cartilage 2003;11:613-622.
24. Onoda T, Morikawa S, Harada T, et al. Antitumor activity of D-mannosamine in vitro: different sensitivities among human leukemia cell lines possessing T-cell properties. Cancer Res 1982;42:2867-2871.
25. Friedman SJ, Skehan P. Membrane-active drugs potentiate the killing of tumor cells by D-glucosamine. Proc Nat Acad Sci U S A 1980;77:1172-1176.
26. Bryson H, Buttle DJ, Kozaci LD, et al. Evidence that the inhibition of cartilage proteoglycan breakdown by mannosamine is not mediated via inhibition of glycosylphosphatidylinositol anchor formation. Biochem J 2000;345:495-501.
27. Arican M, Coughlan AR, Clegg PD, et al. Matrix metalloproteinases 2 and 9 activity in bovine synovial fluids. J Vet Med A Physiol Path Clin Med 2000;47:449-456.
28. Galanos C, Freudenberg MA, Matsuura M. Mechanisms of the lethal action of endotoxin and endotoxin hypersensitivity. Adv Exp Med Biol 1990;256:603-619.
29. Orth MW, Peters TL, Hawkins JN. Inhibition of articular cartilage degradation by glucosamine-HCl and chondroitin sulphate. Equine Vet J Suppl 2002;34:224-229.
30. Wu G, Haynes TE, Li H, et al. Glutamine metabolism to glucosamine is necessary for glutamine inhibition of endothelial nitric oxide synthesis. Biochem J 2001;353:245-252.
31. Grabowski PS, Wright PK, Van't Hof RJ, et al. Immunolocalization of inducible nitric oxide synthase in synovium and cartilage in rheumatoid arthritis and osteoarthritis. Br J Rheumatol 1997;36:651-655.
32. Meininger CJ, Kelly KA, Li H, et al. Glucosamine inhibits inducible nitric oxide synthesis. Biochem Biophys Res Comm 2000; 279:234-239.
33. Little CB, Flannery CR, Hughes CE, et al. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. Biochem J 1999;344:61-68.
34. Byron CR, Orth MW, Venta PJ, et al. Influence of glucosamine on matrix metalloproteinase expression and activity in lipopolysaccharide-stimulated equine chondrocytes. Am J Vet Res 2003;64:666-671.
35. Piperno M, Reboul P, Hellio Le Graverand MP, et al. Glucosamine sulfate modulates dysregulated activities of human osteoarthritic chondrocytes in vitro. Osteoarthritis Cartilage 2000;8:207-212.
36. Bassleer C, Rovati L, Franchimont P. Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro. Osteoarthritis Cartilage 1998;6:427-434.
37. Gouze JN, Bordji K, Gulberti S, et al. Interleukin-1beta down-regulates the expression of glucuronosyltransferase I, a key enzyme priming glycosaminoglycan biosynthesis: influence of glucosamine on interleukin-1beta-mediated effects in rat chondrocytes. Arthritis Rheum 2001;44:351-360.
38. Setnikar I, Rovati LC. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review. Arzneimittelforschung 2001;51:699-725.
39. Adebowale A, Du J, Liang Z, et al. The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs. Biopharm Drug Dispos 2002;23:217-225.
40. Liang Z, Leslie J, Adebowale A, et al. Determination of the nutraceutical, glucosamine hydrochloride, in raw materials, dosage forms and plasma using pre-column derivatization with ultraviolet HPLC. J Pharm Biomed Anal 1999;20:807-814.